Background: It is unknown if health-related quality of life (HRQoL) differs between diseases associated with chronic pruritus (CP). Objective: To analyze HRQoL in relation to age, gender, skin lesions (primary vs. scratch-induced secondary) and itch intensity. Methods: Consecutive patients of our itch clinic were assessed with the Dermatology Life Quality Index (DLQI) and visual analogue scale (VAS). Results: In 510 CP patients (282 females; median age, 61.4 years), DLQI scores and VAS values were highly correlated, irrespective of the type of skin lesion. Overall, women had a lower HRQoL compared to men (females: 10.7 ± 6.7, males: 8.9 ± 6.7), but female gender was only associated with worse quality of life in patients <65 years old. Conclusion: HRQoL impairment in CP is highly influenced by pruritus intensity but not to the visible skin lesion or underlying cause. With limitations to item bias, DLQI is a suitable instrument for estimating quality of life impairment by CP.

Keywords:
Pruritus, Itch, Health-related quality of life, Dermatology Life Quality Index, Visual analogue scale, Gender
1.
Ständer S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, Bergasa NV, Gieler U, Misery L, Wallengren J, Darsow U, Streit M, Metze D, Luger TA, Greaves MW, Schmelz M, Yosipovitch G, Bernhard JD: Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007;87:291-294.
2.
Ständer S, Grundmann SA: Chronic pruritus. G Ital Dermatol Venereol 2012;147:161-169.
3.
Kini SP, DeLong LK, Veledar E, McKenzie-Brown AM, Schaufele M, Chen SC: The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol 2011;147:1153-1156.
4.
Ramakrishnan K, Bond TC, Claxton A, Sood VC, Kootsikas M, Agnese W, Sibbel S: Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms. Int J Nephrol Renovasc Dis 2013;7:1-12.
5.
Reich A, Hrehorow E, Szepietowski JC: Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol 2010;90:257-263.
6.
Sanchez-Pérez J, Daudén-Tello E, Mora AM, Lara Surinyac N: Impact of atopic dermatitis on health-related quality of life in Spanish children and adults: the PSEDA study. Actas Dermosifiliogr 2013;104:44-52.
7.
Schneider G, Driesch G, Heuft G, Evers S, Luger TA, Ständer S: Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol 2006;31:762-767.
8.
Sommer F, Hensen P, Bockenholt B, Metze D, Luger TA, Ständer S: Underlying diseases and co-factors in patients with severe chronic pruritus: a 3-year retrospective study. Acta Derm Venereol 2007;87:510-516.
9.
Tessari G, Dalle Vedove C, Loschiavo C, Tessitore N, Rugiu C, Lupo A, Girolomoni G: The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. J Nephrol 2009;22:241-248.
10.
Krause K, Kessler B, Weller K, Veidt J, Chen SC, Martus P, Church MK, Metz M, Maurer M: German version of ItchyQoL: validation and initial clinical findings. Acta Derm Venereol 2013;93:562-568.
11.
Desai NS, Poindexter GB, Monthrope YM, Bendeck SE, Swerlick RA, Chen SC: A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol 2008;59:234-244.
12.
Carr CW, Veledar E, Chen SC: Factors mediating the impact of chronic pruritus on quality of life. JAMA Dermatol 2014;150:613-620.
13.
Zachariae R, Zachariae CO, Lei U, Pedersen AF: Affective and sensory dimensions of pruritus severity: associations with psychological symptoms and quality of life in psoriasis patients. Acta Derm Venereol 2008;88:121-127.
14.
Phan NQ, Blome C, Fritz F, Gerss J, Reich A, Ebata T, Augustin M, Szepietowski JC, Ständer S: Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol 2012;92:502-507.
15.
Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, Furue M, Blome C, Augustin M, Ständer S, Szepietowski JC: Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol 2012;92:497-501.
16.
Ständer S, Stumpf A, Osada N, Wilp S, Chatzigeorgakidis E, Pfleiderer B: Gender differences in chronic pruritus: women present different morbidity, more scratch lesions and higher burden. Br J Dermatol 2013;168:1273-1280.
17.
Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-216.
18.
Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY: Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005;125:659-664.
19.
Zhu B, Edson-Heredia E, Guo J, Maeda-Chubachi T, Shen W, Kimball AB: Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial. Br J Dermatol 2014;171:1215-1219.
20.
Weisshaar E, Apfelbacher C, Jäger G, Zimmermann E, Bruckner T, Diepgen TL, Gollnick H: Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol 2006;155:957-964.
21.
Yosipovitch G, Goon A, Wee J, Chan YH, Goh CL: The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000;143:969-973.
22.
Ständer S, Augustin M, Reich A, et al: Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. Acta Derm Venereol 2013;93:509-514.
23.
Zhu B, Edson-Heredia E, Guo J, Maeda-Chubachi T, Shen W, Kimball AB: Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial. Br J Dermatol 2014;171:1215-1219.
24.
Tan WS, Tey HL: Extensive prurigo nodularis: characterization and etiology. Dermatology 2014;228:276-280.
25.
Dazzi C, Erma D, Piccinno R, Veraldi S, Caccialanza M: Psychological factors involved in prurigo nodularis: a pilot study. J Dermatolog Treat 2011;22:211-214.
26.
Schneider G, Hockmann J, Ständer S, Luger TA, Heuft G: Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: results of a case-control study. Br J Dermatol 2006;154:61-66.
27.
Siepmann D, Lotts T, Blome C, et al: Evaluation of the antipruritic effects of topical pimecrolimus in non-atopic prurigo nodularis: results of a randomized, hydrocortisone-controlled, double-blind phase II trial. Dermatology 2013;227:353-360.
28.
Ongenae K, Van Geel N, De Schepper S, Naeyaert JM: Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol 2005;152:1165-1172.
29.
Berg M, Lindberg M: Possible gender differences in the quality of life and choice of therapy in acne. J Eur Acad Dermatol Venereol 2011;25:969-972.
30.
Mabuchi T, Yamaoka H, Kojima T, Ikoma N, Akasaka E, Ozawa A: Psoriasis affects patient's quality of life more seriously in female than in male in Japan. Tokai J Exp Clin Med 2012;37:84-88.
31.
Stangier U, Ehlers A, Gieler U: Measuring adjustment to chronic skin disorders: validation of a self-report measure. Psychol Assess 2003;15:532-549.
32.
Sampogna F, Chren MM, Melchi CF, Pasquini P, Tabolli S, Abeni D; Italian Multipurpose Psoriasis Research on Vital Experiences (Improve) Study Group: Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol 2006;154:325-331.
33.
Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY: The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008;159:997-1035.
34.
Lewis V, Finlay AY: 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 2004;9:169-180.
35.
Nijsten T: Dermatology life quality index: time to move forward. J Invest Dermatol 2012;132:11-13.
36.
Finlay AY, Basra MK, Piguet V, Salek MS: Dermatology life quality index (DLQI): a paradigm shift to patient-centered outcomes. J Invest Dermatol 2012;132:2464-2465.
37.
Twiss J, Meads DM, Preston EP, Crawford SR, McKenna SP: Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis? J Invest Dermatol 2012;132:76-84.
38.
Lennox RD, Leahy MJ: Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Ann Allergy Asthma Immunol 2004;93:142-146.
39.
Mørk C, Wahl A, Moum T: The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics. Acta Derm Venereol 2002;82:347-351.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.